Related Experiment Videos
Mononuclear phagocytic system stimulation. Protective role from glomerular immune complex deposition
The Journal of Laboratory and Clinical Medicine
|October 1, 1981
Summary
Stimulating the mononuclear phagocyte system (MPS) enhanced clearance of immune complexes (ICs) in rats. This MPS stimulation reduced circulating ICs and protected glomeruli from IC deposition, suggesting therapeutic potential.
Area of Science:
- Immunology
- Nephrology
Background:
- Glomerular deposition of immune complexes (ICs) is linked to glomerulonephritis.
- Dysfunction in the mononuclear phagocyte system (MPS) and its Fc receptor-mediated clearance of ICs is associated with autoimmune diseases.
Purpose of the Study:
- To investigate if stimulating the MPS can reduce circulating ICs and subsequent glomerular deposition.
- To test the hypothesis that MPS stimulation is beneficial in preventing IC-mediated glomerular injury.
Main Methods:
- Rats with ZY-stimulated MPS were compared to control rats.
- Both groups received radiolabeled human IgG (AHIgG . 125I), a model for ICs.
- Glomerular, hepatic, splenic, lung, and blood AHIgG . 125I levels were measured over 24 hours.
Main Results:
- ZY-stimulated MPS rats showed a 40% shorter blood half-life for AHIgG . 125I.
- Circulating AHIgG . 125I levels were significantly lower in ZY-treated rats at 4 and 8 hours.
- Glomerular AHIgG . 125I deposition was reduced proportionally to decreased blood levels, with increased hepatic and splenic uptake.
Conclusions:
- ZY stimulation of the MPS effectively increased the clearance of AHIgG . 125I.
- MPS stimulation protected glomeruli from AHIgG . 125I deposition, suggesting Fc-receptor-mediated mechanisms.
- Agents that stimulate the MPS may offer a novel therapeutic strategy for IC-mediated glomerular injury.